Today, CME Group Inc. (CME) Short Interest Up 37.7% in November

Today, CME Group Inc. (CME) Short Interest Up 37.7% in November

CME Group Inc. (NASDAQ:CME) was the recipient of a large growth in short interest in the month of November. As of November 15th, there was short interest totalling 6,959,808 shares, a growth of 37.7% from the October 31st total of 5,052,862 shares. Based on an average trading volume of 2,603,900 shares, the short-interest ratio is currently 2.7 days. Approximately 2.2% of the shares of the company are sold short.

Several research firms have issued reports on CME. JPMorgan Chase & Co. cut CME Group from an “overweight” rating to a “neutral” rating and set a $116.00 target price on the stock. in a research report on Monday, November 14th. They noted that the move was a valuation call. RBC Capital Markets set a $92.00 target price on CME Group and gave the stock a “sell” rating in a research report on Friday, October 28th. Royal Bank Of Canada dropped their target price on CME Group from $97.00 to $92.00 and set an “underperform” rating on the stock in a research report on Friday, October 28th. Jefferies Group reiterated a “buy” rating and set a $118.00 target price on shares of CME Group in a research report on Thursday, October 13th. Finally, Deutsche Bank AG boosted their target price on CME Group from $115.00 to $116.00 and gave the stock a “buy” rating in a research report on Wednesday, October 5th. Three analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have issued a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus price target of $102.89.

CME Group (NASDAQ:CME) opened at 112.84 on Friday. The stock has a market cap of $38.29 billion, a price-to-earnings ratio of 26.30 and a beta of 0.81. The firm’s 50 day moving average price is $106.96 and its 200-day moving average price is $102.74. CME Group has a 52 week low of $81.87 and a 52 week high of $117.80.

CME Group (NASDAQ:CME) last announced its quarterly earnings results on Thursday, October 27th. The company reported $1.05 EPS for the quarter, beating the consensus estimate of $1.04 by $0.01. CME Group had a net margin of 41.54% and a return on equity of 6.90%. The company had revenue of $842 million for the quarter, compared to analyst estimates of $855.94 million. During the same quarter last year, the business earned $1.02 earnings per share. CME Group’s revenue was down 1.0% compared to the same quarter last year. Analysts expect that CME Group will post $4.35 EPS for the current year.

The company also recently declared a quarterly dividend, which will be paid on Wednesday, December 28th. Shareholders of record on Friday, December 9th will be paid a $0.60 dividend. The ex-dividend date of this dividend is Wednesday, December 7th. This represents a $2.40 annualized dividend and a dividend yield of 2.13%. CME Group’s payout ratio is currently 55.94%.

In related news, Director Dennis Suskind sold 1,000 shares of the business’s stock in a transaction dated Thursday, September 1st. The stock was sold at an average price of $109.49, for a total value of $109,490.00. Following the transaction, the director now owns 10,099 shares in the company, valued at approximately $1,105,739.51. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Kimberly S. Taylor sold 2,300 shares of the business’s stock in a transaction dated Tuesday, August 30th. The shares were sold at an average price of $107.16, for a total value of $246,468.00. Following the completion of the transaction, the insider now owns 101,489 shares in the company, valued at approximately $10,875,561.24. The disclosure for this sale can be found here. 0.61% of the stock is owned by corporate insiders.

Several large investors have recently made changes to their positions in the stock. Gofen & Glossberg LLC IL raised its stake in shares of CME Group by 0.4% in the second quarter. Gofen & Glossberg LLC IL now owns 7,323 shares of the company’s stock valued at $713,000 after buying an additional 26 shares during the last quarter. Capstone Asset Management Co. raised its position in CME Group by 4.9% in the second quarter. Capstone Asset Management Co. now owns 29,334 shares of the company’s stock worth $2,857,000 after buying an additional 1,372 shares in the last quarter. NN Investment Partners Holdings N.V. raised its position in CME Group by 4.5% in the second quarter. NN Investment Partners Holdings N.V. now owns 16,325 shares of the company’s stock worth $1,590,000 after buying an additional 700 shares in the last quarter. Beacon Financial Group raised its position in CME Group by 0.8% in the second quarter. Beacon Financial Group now owns 4,525 shares of the company’s stock worth $435,000 after buying an additional 38 shares in the last quarter. Finally, Hefty Wealth Partners raised its position in CME Group by 8.6% in the second quarter. Hefty Wealth Partners now owns 8,573 shares of the company’s stock worth $835,000 after buying an additional 680 shares in the last quarter. Institutional investors own 79.09% of the company’s stock.

About CME Group

Related posts

Leave a Comment